| |
|
|
|
Endra Life Sciences Inc  
|
|
1.75 -0.04 (-0.02%) |
09-17 16:00 |
|
Open: |
1.77 |
Pre close: |
1.79 |
Target:
|
2.44
|
|
High: |
1.78 |
Low: |
1.67 |
Resistance:
|
2.09
2.44
|
|
Volume: |
238,817 |
Market Cap: |
73M |
Support:
|
1.57
1.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.77
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.85  |
Signal(12,26,9): |
0.01 |
|
MA(100): |
2.00 |
Stochastic Oscillator |
%K(14,3):
|
25.00 |
|
MA(250): |
1.71 |
%D(3): |
27.27 |
|
Average Volume(K) |
3-Month: |
1626030
|
52-Week |
High:
|
3.10 |
|
10-Days: |
205313 |
Low: |
0.65 |
|
RSI |
RSI(14):
|
45.28 |
Change(%): |
130.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.434 |
Return on Equity (ttm) |
-137.5 |
Shares Out. (M) |
41.67 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-70.2 |
Shares Float (M) |
38.45 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.45 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
9.63 |
|
Forward EPS |
-2.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
782 |
|
Book Value (p.s.) |
0.430 |
EBITDA (p.s.) |
-0.268 |
P/E |
-4.03 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.93 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.61 |
P/CF |
-7.34 |
|
|
|
|
|
|
